What is Selegiline?
Selegiline is a Monoamine Oxidase (MAO) inhibitor. It is an antidepressant and anti-Parkinson's agent. When used in combination with levodopa containing drugs such as Sinemet it can improve their efficacy by slowing the breakdown of levodopa. The transdermal product is used to treat depression.
Reasons taken & Efficacy
| Reasons taken | # of patients | Major | Moderate | Slight | None | Can’t tell | # of patients evaluated by |
|---|---|---|---|---|---|---|---|
| Other | 2 |
|
1 |
Mouse over the table for more information
Currently Taking Selegiline
| 0-1 month | 1-3 months | 3-6 months | 6 months-1year | 1-2 years | 2 years or more |
|---|---|---|---|---|---|
|
0
|
0
|
0
|
0
|
0
|
Adherence, Burden & Cost See details from patient evaluations ▼
See more information, including instructions, precautions, side effects, and interactions.
Report created on November 22, 2009.